Table 2.

Acute and Late Toxicities of Treatment

	Overall	IMRT	CC-IMRT	p-Value
Acute (grade 3+), n (%)	(N = 88)	(N = 43)	(N = 45)
Dermatitis	16 (18.2%)	4 (9.3%)	12 (26.7%)	0.052
Nausea	1 (1.1%)	1 (2.3%)	0 (0%)	0.489
Vomiting	2 (2.3%)	2 (4.7%)	0 (0%)	0.236
Mucositis	8 (9.1%)	6 (14.0%)	2 (4.4%)	0.152
Xerostomia	0 (0%)	0 (0%)	0 (0%)	1.000
Dysphagia	6 (6.8%)	3 (7.0%)	3 (6.7%)	1.000
Hoarseness	3 (3.4%)	1 (2.3%)	2 (4.4%)	1.000
Fatigue	3 (3.4%)	1 (2.3%)	2 (4.4%)	1.000
Late (grade 2+), n (%)	(N = 78)	(N = 39)	(N = 39)
Dermatitis	1 (1.3%)	1 (2.6%)	0 (0%)	1.000
Xerostomia	7 (9.0%)	6 (15.4%)	1 (2.6%)	0.108
Dysphagia	8 (10.3%)	7 (17.9%)	1 (2.6%)	0.056
Hoarseness	0 (0%)	0 (0%)	0 (0%)	1.000
	(N = 88)	(N = 43)	(N = 45)
PEG During or within 60 days of RT, n (%)	13 (14.8%)	3 (7.0%)	10 (22.2%)	0.070
PEG >60 days post RT, n (%)	2 (2.3%)	2 (4.7%)	0 (0%)	0.236
Trach during or within 60 days of RT, n (%)	3 (3.4%)	1 (2.3%)	2 (4.4%)	1.000
Trach >60 days post RT, n (%)	5 (5.7%)	2 (4.7%)	3 (6.7%)	1.000